Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity. (Q40457478)
scientific article published on February 2005
Language:
(P31) (Q13442814)
(P304) 1107-1131
(P407) (Q1860)
(P433) 4
(P478) 48
(P577) Tuesday, February 1, 2005
(P921) (Q6995920)
(P1433) (Q900316)
(P1476) "Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity." (language: en)
(P2093) Hwei-Ru Tsou
Elsebe G Overbeek-Klumpers
William A Hallett
Marvin F Reich
M Brawner Floyd
Bernard D Johnson
Ronald S Michalak
Ramaswamy Nilakantan
Carolyn Discafani
Jonathan Golas
Sridhar K Rabindran
Ru Shen
Xiaoqing Shi
Yu-Fen Wang
Janis Upeslacis
Allan Wissner
other details
description scientific article published on February 2005

External Links